PAR 5.68% 23.3¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-17

  1. 339 Posts.
    lightbulb Created with Sketch. 129
    Main reason the retail CR was unsuccessful last time round was the long wait between when insto's are offered the stock and when retail are offered. By the time the retail deadline was reached, the share price was sold down to under the offer price. Not really a comparable and fair process but that is how all CR's are done. I was keen to participate but when the share price falls to under the offer price, why would one participate. I can assure you that any insto would have not participated if the offer price was above the market price.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.3¢
Change
0.013(5.68%)
Mkt cap ! $78.70M
Open High Low Value Volume
22.8¢ 23.3¢ 22.5¢ $18.36K 79.69K

Buyers (Bids)

No. Vol. Price($)
2 55397 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 149266 10
View Market Depth
Last trade - 12.36pm 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.